// App-Quantinova.ai

O-128 : Letrozole co-treatment during ovarian stimulation in antagonist cycles augments follicle growth and exerts pronounced effects on endocrinology: a randomized controlled trial

Researchers

Presenter

  • L.L.C Poulsen

Principal Investigators

  • A.K Warzecha

  • N.S Bülow

  • L Bungum

  • N.S Macklon

  • C Yding Andersen

  • S.O Skouby

Medical Centers

  • Rigshospitalet-, Laboratory of Reproductive Biology- Section 5701., Copenhagen-, Denmark

  • Rigshopitalet, The Fertility Department, Copenhagen, Denmark

  • Zealand University Hospital, Gynaecology and Obstetrics, Køge, Denmark

  • Herlev Hospital, Gynaecology and Obstetrics, Herlev, Denmark

  • London Women's Clinic, Harley Street, London, United Kingdom

Locations

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • Follicle-stimulating hormone

  • Inhibin A

Drug/Treatment

  • Letrozole

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved